Management Strategies of Acute Retinal Necrosis: Current Perspectives
Brittany Powell, Daniel Wang, Stephanie Llop, Richard B Rosen Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, United StatesCorrespondence: Richard B RosenNew York Eye and Ear Infirmary of Mount Sinai, 310 East 14th Street, New York, NY 10003 Tel +1 212-979-4...
Guardado en:
Autores principales: | Powell B, Wang D, Llop S, Rosen RB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d948134bea8458bafd8a507afde993c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan HY, et al.
Publicado: (2016) -
Antiviral selection in the management of acute retinal necrosis
por: Patrick MK Tam, et al.
Publicado: (2009) -
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail A, et al.
Publicado: (2018) -
Kyrieleis´ vasculitis in acute retinal necrosis
por: Ester Francés-Muñoz, et al.
Publicado: (2010) -
Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
por: Wallsh J, et al.
Publicado: (2020)